Document Detail

Serologic studies on schizophrenic patients.
MedLine Citation:
PMID:  687795     Owner:  NLM     Status:  MEDLINE    
We studied the capacity of sera from schizophrenic patients and from normal blood bank donors to agglutinate sheep erythrocytes coated with extracts of human brain. Passive hemagglutination of coated erythrocytes was obtained with 36.4% of the assayed sera of the schizophrenia patients and with 11% of the control sera. Drug treatment did not seem to play a major role in the reactivity because the patients were either never treated before or a period of several weeks was allowed since treatment until blood was drawn. Furthermore, the analysis of sera obtained by sequential bleedings of patients on drug therapy showed that drugs did not affect the serologic activity.
R Anavi; M Baron; I P Witz
Related Documents :
4089185 - The assessment of a psychosocial treatment with chronic schizophrenic patients using ne...
8416025 - Serum homovanillic acid levels in schizophrenic patients and normal control subjects.
7870855 - P300 asymmetries in schizophrenia revisited with reference-independent methods.
11595395 - Reduced naa in the thalamus and altered membrane and glial metabolism in schizophrenic ...
11354555 - Power doppler sonography in knee arthritis--a pilot study.
19151995 - Extended preoperative patient education using a multimedia dvd-impact on patients recei...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Birth defects original article series     Volume:  14     ISSN:  0547-6844     ISO Abbreviation:  Birth Defects Orig. Artic. Ser.     Publication Date:  1978  
Date Detail:
Created Date:  1978-11-22     Completed Date:  1978-11-22     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0003403     Medline TA:  Birth Defects Orig Artic Ser     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  297-309     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Bipolar Disorder / immunology
Caudate Nucleus / immunology
Cerebellum / immunology
Chlorpromazine / therapeutic use
Erythrocytes / immunology
Hemagglutination Tests
Lung / immunology
Middle Aged
Schizophrenia / drug therapy,  immunology*
Septal Nuclei / immunology
Spleen / immunology
Tissue Extracts / immunology
Reg. No./Substance:
0/Tissue Extracts; 50-53-3/Chlorpromazine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Alterations in behavior resulting from persistent lymphocytic choriomeningitis virus infection.
Next Document:  Comparative assessment of circulatory and respiratory maintenance by hemoglobin dissolved in plasma ...